FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

863993005: Nintedanib esilate (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2020. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3951806011 Nintedanib esilate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3951807019 Nintedanib esilate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Nintedanib esilate (substance) Is a Enzyme inhibitor false Inferred relationship Some
Nintedanib esilate (substance) Is a Piperazine derivative true Inferred relationship Some
Nintedanib esilate (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Protein kinase inhibitor (disposition) true Inferred relationship Some
Nintedanib esilate (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Nintedanib (substance) true Inferred relationship Some
Nintedanib esilate (substance) Is a Antineoplastic agent (substance) true Inferred relationship Some
Nintedanib esilate (substance) Is a Protein kinase inhibitor true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely nintedanib (as nintedanib esilate) 150 milligram/1 each conventional release oral capsule (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Nintedanib esilate (substance) Inferred relationship Some 1
Nintedanib (as nintedanib esilate) 100 mg oral capsule The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Nintedanib esilate (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start